Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

16
Number of overlapping holdings
32.7%
% of FTXH's 51 holdings also in IHE
47.1%
% of IHE's 34 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in IHE |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 7.3% | 23.4% | 7.3% | |
MERCK & CO. INC. | 7.3% | 4.7% | 4.7% | |
PFIZER INC | 6.7% | 4.3% | 4.3% | |
ELI LILLY & CO | 4.2% | 26.1% | 4.2% | |
BRISTOL-MYERS SQUIBB CO | 6.3% | 4.1% | 4.1% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to IHE
ABBVIE INC | 7.4% | |
CARDINAL HEALTH INC | 4.7% | |
AMGEN INC | 4.0% | |
VERTEX PHARMACEUTICALS INC | 4.0% | |
GILEAD SCIENCES INC | 3.9% | |
REGENERON PHARMACEUTICALS | 3.8% | |
BIOGEN IDEC INC | 3.4% | |
UNITED THERAPEUTICS CORP | 3.3% | |
MERCK & CO. INC. | 2.6% | |
PFIZER INC | 2.4% |
FTXH Underweight Relative to IHE
ELI LILLY & CO | -21.9% | |
JOHNSON & JOHNSON | -16.1% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
CATALENT INC | -2.4% | |
ELANCO ANIMAL HEALTH, INC. | -2.0% | |
INTRA-CELLULAR THERAPIES INC | -1.7% | |
VIATRIS, INC. | -1.1% | |
ZOETIS INC | -1.0% | |
CORCEPT THERAPEUTICS INC | -1.0% | |
PERRIGO CO | -0.9% |